97 results on '"Aldape, Kenneth"'
Search Results
2. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors
3. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor
4. Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case
5. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
6. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
7. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities
8. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature
9. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
10. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
11. Estimation of cell lineages in tumors from spatial transcriptomics data
12. Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes
13. The multiomic landscape of meningiomas: a review and update
14. Molecular classification and grading of meningioma
15. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1
16. Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions
17. Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases
18. Big data in basic and translational cancer research
19. The role of methylation profiling in histologically diagnosed neurocytoma: a case series
20. Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor types
21. Recurrent ACVR1 mutations in posterior fossa ependymoma
22. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival
23. A T cell resilience model associated with response to immunotherapy in multiple tumor types
24. Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes
25. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology
26. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
27. Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma
28. Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumors
29. A clinically applicable integrative molecular classification of meningiomas
30. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors
31. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
32. TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy
33. A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations
34. Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
35. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
36. Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
37. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
38. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
39. Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
40. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
41. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
42. Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
43. Reply to ‘Assembling the brain trust: the multidisciplinary imperative in neuro-oncology’
44. CIC protein instability contributes to tumorigenesis in glioblastoma
45. Challenges to curing primary brain tumours
46. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
47. Heterogeneity within the PF-EPN-B ependymoma subgroup
48. DNA methylation-based classification of central nervous system tumours
49. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
50. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.